IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1410
Positioning
Market Dominance
Services
Business Services
$3.4B
Catherine F. Corrigan
Exponent, Inc. operates in Engineering and Other Scientific, and Environmental and Health. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = EXPO ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$EXPO EXPONENT INC | 54 | 64 | 57 | 60 | 32.0x | 27.5x | 27.1% | 14.3% | 35.9% | 15.9% | 18.9% | 1.1% | 1.8% | 89.0x | $3.4B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
EXPONENT INC (EXPO) receives a "Hold" rating with a composite score of 53.9/100. It ranks #1410 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
In-line with peers — no strong momentum signal
Fair valuation relative to peers
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for EXPO.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 64 | 79 | -15DRAG |
| MOMENTUM | 60 | 63 | -3NEUTRAL |
| VALUATION | 57 | 62 | -5NEUTRAL |
| INVESTMENT | 42 | 73 | -31DRAG |
| STABILITY | 80 | 88 | -8DRAG |
| SHORT INT | 25 | 10 | +15ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 27.1% (sector 5.7%)
GM 36% vs sector 65%, OM 16% vs sector 5%
Capital turnover N/A
Rev growth 1%, 11yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate EXPONENT INC (EXPO) as a Hold with a composite score of 53.9/100 at a current price of $70.22. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
EXPONENT INC holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 53.9/100 places it at rank #1410 in our full universe.
Narrow
Low
Exemplary
Fair Value
Returns on equity of 27.1% exceed cost of capital.
Stable competitive position in a defensive sector.
Vulnerability to macroeconomic shocks and interest rate volatility.
EXPONENT INC represents a hold based on multi-factor quantitative performance.
Our model assigns EXPONENT INC a Hold rating, with a composite score of 53.9/100 and 3 out of 5 stars. Ranked #1410 of 7,333 stocks, EXPO presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 64/100, EXPO shows adequate but unremarkable business quality. The company reports a return on equity of 27.1% (sector avg: 5.7%), gross margins of 35.9% (sector avg: 64.6%), net margins of 18.9% (sector avg: 2.8%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
EXPO's value score of 57/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 32.05x, an EV/EBITDA of 27.54x, a P/B ratio of 8.69x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
With an investment score of 42/100, EXPO exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 1.1% vs. a sector average of 8.6% and a return on assets of 14.3% (sector: 2.4%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
EXPO demonstrates moderate momentum with a score of 60/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 1.1% year-over-year, while a beta of 0.66 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
EXPO shows good financial stability with a score of 80/100. Key stability metrics include a beta of 0.66 and a debt-to-equity ratio of 89.00x (sector avg: 0.3x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
EXPONENT INC's short interest score of 25/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 89.00x). At $3.4B (mid-cap), EXPO carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
EXPO offers a modest dividend yield of 1.8%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
EXPONENT INC is a mid-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #1410 of 7,333 overall (81st percentile). Key comparisons include ROE of 27.1% exceeding the 5.7% sector median and operating margins of 15.9% above the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While EXPO currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Stability (80) vs Short Int. (25) — closing this gap could shift the rating.
EV/EBITDA 135% ABOVE SECTOR MEDIAN
ROE 372% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 45% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081

Conestoga Capital Advisors sold 344,631 shares of Exponent, valued at $24.63 million, reducing its stake from 2.99% to 2.63% of its portfolio in Q3 2025. The sale comes amid Exponent's underperformance compared to the S&P 500.
Exponent (EXPO) shares moved sharply after fourth quarter 2025 results topped expectations, management projected high single digit revenue growth and margin expansion for 2026, and the board approved a higher quarterly dividend. See our latest analysis for Exponent. At a share price of $78.34, Exponent has a 7 day share price return of 6.35% and a 90 day share price return of 10.42%. However, the 1 year total shareholder return of a 12.42% decline suggests recent momentum follows a weaker...

Exponent (NASDAQ: EXPO) reported strong Q4 2025 results with total revenues increasing 7.8% to $147.4 million and net income rising to $24.8 million ($0.49 per diluted share). For fiscal year 2025, revenues grew 4.2% to $582.0 million with net income of $106.0 million ($2.07 per diluted share). The company increased its quarterly dividend from $0.30 to $0.31 and provided guidance for FY2026 expecting high-single-digit revenue growth with EBITDA margins of 27.6% to 28.1%.

Exponent Inc. (NASDAQ: EXPO) announced that its Board of Directors has increased its quarterly cash dividend from $0.30 to $0.31 per share, effective for Q1 2026. The dividend will be paid on March 20, 2026 to shareholders of record as of March 6, 2026. CEO Dr. Catherine Corrigan attributed the increase to strong market drivers and confidence in the company's scientific and engineering capabilities.
Anyone interested in Exponent, Inc. ( NASDAQ:EXPO ) should probably be aware that a company insider, John Pye, recently...